PCLAF
PCNA-associated factor
Also known as: KIAA0101, NS5ATP9, OEATC-1, p15(PAF), PAF15, PAF15_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15004
- Gene
- PCLAF
- Ensembl
- ENSG00000166803
- Chromosome
- 15
- Canonical length
- 111 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centrosome
OverviewNCBI Gene
Enables chromatin binding activity and molecular adaptor activity. Involved in several processes, including DNA metabolic process; centrosome cycle; and response to UV. Located in centrosome; nucleus; and perinuclear region of cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
111 residues, UniProt reviewed canonical sequence.
>Q15004|PCLAF
1 MVRTKADSVP GTYRKVVAAR APRKVLGSST SATNSTSVSS RKAENKYAGG NPVCVRPTPK
61 WQKGIGEFFR LSPKDSEKEN QIPEEAGSSG LGKAKRKACP LQPDHTNDEK ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against PCLAF can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.69
- Highest tissue expression
- 121 nTPM
Expression across tissuesHPA
Tissue
- bone marrow: 121 nTPM
- thymus: 69 nTPM
- lymph node: 46 nTPM
- tonsil: 44 nTPM
- appendix: 22 nTPM
- rectum: 21 nTPM
Single-cell type
- late spermatids: 165 nCPM
- early spermatids: 30 nCPM
- erythrocyte progenitors: 27 nCPM
- monocyte progenitors: 17 nCPM
- megakaryocyte progenitors: 14 nCPM
- gastric progenitor cells: 14 nCPM
Immune cell
- T-reg: 24 nTPM
- NK-cell: 5.7 nTPM
- memory CD4 T-cell: 4.4 nTPM
- memory CD8 T-cell: 4.2 nTPM
- myeloid DC: 2.9 nTPM
- neutrophil: 2.5 nTPM
Brain region
- white matter: 5.8 nTPM
- cerebellum: 5 nTPM
- medulla oblongata: 4.3 nTPM
- cerebral cortex: 4.2 nTPM
- thalamus: 4.2 nTPM
- basal ganglia: 4.1 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.02
- gnomAD pLI
- 0.16
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- centrosome cycle
- DNA damage response
- DNA repair
- DNA replication
- regulation of cell cycle
- response to UV
- translesion synthesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- PCNA-associated factor, histone-like domain
- PCNA-associated factor
- PCNA-associated factor histone like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PCLAF in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PCLAF as an antibody target. Whether an autoantibody or antibody against PCLAF could matter depends on whether native PCLAF is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PCLAF is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PCLAF as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...